HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuko Hirai Selected Research

TAK-070

8/2010A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuko Hirai Research Topics

Disease

1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
05/2018
1Alcoholism (Alcohol Abuse)
04/2017
1Alzheimer Disease (Alzheimer's Disease)
08/2010
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
05/2009
1Ischemia
05/2009
1Hypothermia
05/2009
1Atopic Dermatitis (Atopic Eczema)
01/2004

Drug/Important Bio-Agent (IBA)

1Guanfacine (Tenex)FDA LinkGeneric
05/2018
1Methylphenidate (Ritalin)FDA LinkGeneric
05/2018
1Ethanol (Ethyl Alcohol)IBA
04/2017
1TAK-070IBA
08/2010
1Peptide Hydrolases (Proteases)FDA Link
08/2010
1Peptides (Polypeptides)IBA
08/2010
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
05/2009
1Proteins (Proteins, Gene)FDA Link
05/2009
1Messenger RNA (mRNA)IBA
05/2009
1Neuroprotective AgentsIBA
05/2009

Therapy/Procedure

1Therapeutics
01/2004